Re: A Phase III Trial to Investigate the Timing of Radiotherapy for Prostate Cancer with High-Risk Features: Background and Rationale of the Radiotherapy—Adjuvant versus Early Salvage (RAVES) Trial

Samir Taneja

doi:https://doi.org/10.1016/j.juro.2014.11.067

Re: A Phase III Trial to Investigate the Timing of Radiotherapy for Prostate Cancer with High-Risk Features: Background and Rationale of the Radiotherapy—Adjuvant versus Early Salvage (RAVES) Trial

Samir Taneja

Biomedical Engineering

Research output: Contribution to journal › Article › peer-review

Original language	English (US)
Journal	The Journal of Urology
DOIs	https://doi.org/10.1016/j.juro.2014.11.067
State	Published - 2015

Access to Document

https://doi.org/10.1016/j.juro.2014.11.067

Cite this

@article{603bfaa6c200484594d63750406deee2,

title = "Re: A Phase III Trial to Investigate the Timing of Radiotherapy for Prostate Cancer with High-Risk Features: Background and Rationale of the Radiotherapy—Adjuvant versus Early Salvage (RAVES) Trial",

author = "Samir Taneja",

year = "2015",

doi = "https://doi.org/10.1016/j.juro.2014.11.067",

language = "English (US)",

journal = "The Journal of Urology",

issn = "0022-5347",

}

TY - JOUR

T1 - Re: A Phase III Trial to Investigate the Timing of Radiotherapy for Prostate Cancer with High-Risk Features: Background and Rationale of the Radiotherapy—Adjuvant versus Early Salvage (RAVES) Trial

AU - Taneja, Samir

PY - 2015

Y1 - 2015

U2 - https://doi.org/10.1016/j.juro.2014.11.067

DO - https://doi.org/10.1016/j.juro.2014.11.067

M3 - Article

JO - The Journal of Urology

JF - The Journal of Urology

SN - 0022-5347

ER -